# A Study to Learn About the Study Medicine PF-07853578 and How it Acts in the Bodies of Healthy Adults

> **NCT05890105** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 23 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** PF-07853578
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05890105
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-02
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05890105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05890105, "A Study to Learn About the Study Medicine PF-07853578 and How it Acts in the Bodies of Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05890105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*